McKesson Corporation (MCK)
Stock Price:
$156.41 USD
2.18 (1.41%)
Updated Oct 23, 2020 4:03 PM EDT - Market closed
Key Info
| Market Cap |
25.37B |
| Revenue (ttm) |
231.00B |
| Net Income (ttm) |
921.00M |
| Shares Out |
162.19M |
| EPS (ttm) |
5.25 |
| PE Ratio |
29.79 |
| Forward PE |
10.29 |
| Dividend |
$1.68 |
| Dividend Yield |
1.07% |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$156.41 |
| Previous Close |
$154.23 |
| Change ($) |
2.18 |
| Change (%) |
1.41% |
| Day's Open |
155.07 |
| Day's Range |
154.38 - 156.55 |
| Day's Volume |
556,634 |
| 52-Week Range |
112.60 - 172.18 |
More Stats
| Market Cap |
25.37B |
| Enterprise Value |
32.19B |
| Earnings Date (est) |
Nov 3, 2020 |
| Ex-Dividend Date |
Aug 31, 2020 |
| Shares Outstanding |
162.19M |
| Float |
162.10M |
| EPS (basic) |
5.43 |
| EPS (diluted) |
5.25 |
| FCF / Share |
17.60 |
| Dividend |
$1.68 |
| Dividend Yield |
1.07% |
| Earnings Yield |
3.36% |
| FCF Yield |
11.24% |
| Payout Ratio |
30.20% |
| Shares Short |
2.11M |
| Short Ratio |
1.72 |
| Short % of Float |
1.30% |
| Beta |
0.75 |
| PE Ratio |
29.79 |
| Forward PE |
10.29 |
| P/FCF Ratio |
8.90 |
| PS Ratio |
0.11 |
| PB Ratio |
4.59 |
| Revenue |
231.00B |
| Operating Income |
2.53B |
| Net Income |
921.00M |
| Free Cash Flow |
2.85B |
| Net Cash |
-6.82B |
| Net Cash / Share |
-42.05 |
| Gross Margin |
5.20% |
| Operating Margin |
1.10% |
| Profit Margin |
0.40% |
| FCF Margin |
1.23% |
| ROA |
2.94% |
| ROE |
13.77% |
| ROIC |
7.90% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (19)
| Buy |
12 |
| Overweight |
1 |
| Hold |
6 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$184.69*
(18.08% upside)
Low
150
Current: $156.41
High
210
Target: 184.69
*Average 12-month price target from 16 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|
| Revenue | 231,051 | 214,319 | 208,357 | 198,533 | 190,884 | 179,045 | 137,392 | 122,196 | 122,321 | 112,084 |
| Revenue Growth | 7.81% | 2.86% | 4.95% | 4.01% | 6.61% | 30.32% | 12.44% | -0.1% | 9.13% | - |
| Gross Profit | 12,023 | 11,754 | 11,184 | 11,271 | 11,416 | 11,411 | 8,352 | 6,881 | 6,402 | 5,970 |
| Operating Income | 2,489 | 886 | 616 | 3,175 | 3,442 | 2,968 | 2,439 | 2,266 | 2,124 | 1,821 |
| Net Income | 900 | 34.00 | 67.00 | 5,070 | 2,258 | 1,476 | 1,263 | 1,338 | 1,403 | 1,202 |
| Shares Outstanding | 181 | 196 | 208 | 221 | 230 | 232 | 229 | 235 | 246 | 258 |
| Earnings Per Share | 4.95 | 0.17 | 0.32 | 22.73 | 9.70 | 6.27 | 5.41 | 5.59 | 5.59 | 4.57 |
| EPS Growth | 2811.76% | -46.88% | -98.59% | 134.33% | 54.7% | 15.9% | -3.22% | 0% | 22.32% | - |
| Dividend Per Share | 1.62 | 1.51 | 1.30 | 1.12 | 1.08 | 0.96 | 0.92 | 0.80 | 0.80 | 0.72 |
| Dividend Growth | 7.28% | 16.15% | 16.07% | 3.7% | 12.5% | 4.35% | 15% | 0% | 11.11% | - |
| Operating Cash Flow | 4,374 | 4,036 | 4,345 | 4,744 | 3,672 | 3,112 | 3,136 | 2,483 | 2,950 | 2,338 |
| Capital Expenditures | -506 | -557 | -580 | -562 | -677 | -545 | -419 | -400 | -398 | -388 |
| Free Cash Flow | 3,868 | 3,479 | 3,765 | 4,182 | 2,995 | 2,567 | 2,717 | 2,083 | 2,552 | 1,950 |
| Cash & Equivalents | 4,015 | 2,981 | 2,672 | 2,783 | 4,048 | 5,341 | 4,193 | 2,456 | 3,149 | 3,612 |
| Total Debt | 9,401 | 7,595 | 7,880 | 8,545 | 8,114 | 9,844 | 10,594 | 4,873 | 3,980 | 4,004 |
| Net Cash / Debt | -5,386 | -4,614 | -5,208 | -5,762 | -4,066 | -4,503 | -6,401 | -2,417 | -831 | -392 |
| Assets | 61,247 | 59,672 | 60,381 | 60,969 | 56,523 | 53,870 | 51,759 | 34,786 | 33,093 | 30,886 |
| Liabilities | 55,938 | 51,385 | 50,324 | 49,696 | 47,515 | 45,785 | 41,441 | 27,716 | 26,262 | 23,666 |
| Book Value | 5,092 | 8,094 | 9,804 | 11,095 | 8,924 | 8,001 | 8,522 | 7,070 | 6,831 | 7,220 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
McKesson Corporation |
| Country |
United States |
| Employees |
60,000 |
| CEO |
Brian Scott Tyler |
Stock Information
| Ticker Symbol |
MCK |
| Stock Exchange |
New York Stock Exchange |
| Sector |
Healthcare |
| Industry |
Medical Distribution |
| Unique Identifier |
NYSE: MCK |
Description
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, Prescription Technology Solutions, International, and Medical-Surgical Solutions. The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment provides practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices; and solutions for life sciences companies, including offering multiple distribution channels and clinical trial access to specific patient populations through its network of oncology physicians. The segment also sells financial, operational and clinical solutions to pharmacies; and offers consulting, outsourcing, and other services. The Prescription Technology Solutions segment operates in the healthcare delivery system to connect pharmacies, providers, payers, and biopharma for next-generation patient access and adherence solutions. The International segment provides drug distribution services, specialty pharmacy, and retail and infusion care services. The Medical-Surgical Solutions segment distributes medical-surgical supplies and provides logistics and other services to healthcare providers. McKesson Corporation was founded in 1833 and is headquartered in Irving, Texas.